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Abstract
Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders that are highly heterogeneous in clinical
symptoms as well as etiologies. Mutations in SHANK2 are associated with ASD and accordingly, Shank2 knockout
mouse shows ASD-like behavioral phenotypes, including social deficits. Intriguingly, two lines of Shank2 knockout (KO)
mouse generated by deleting different exons (exon 6–7 or exon 7) showed distinct cellular phenotypes. Previously, we
compared gene expressions between Shank2 KOs lacking exon 6–7 (e6–7 KO) and KOs lacking exon 7 (e7 KO) by
performing RNA-seq. In this study, we expanded transcriptomic analyses to identify novel transcriptional variants in the
KO mice. We found prominent expression of a novel exon (exon 4′ or e4’) between the existing exons 4 and 5 in the
Shank2 e6–7 KO model. Expression of the transcriptional variant harboring this novel exon was confirmed by RT-PCR
and western blotting. These findings suggest that the novel variant may function as a modifier gene, which contributes
to the differences between the two Shank2 mutant lines. Furthermore, our result further represents an example of
genetic compensation that may lead to phenotypic heterogeneity among ASD patients with mutations in the same
gene.
Keywords: Autism spectrum disorder, RNA-seq, Shank2
Introduction
Autism spectrum disorder (ASD) is a group of neurodeve-
lopmental disorders that are diagnosed by impairments in
social–communication and restricted, repetitive behaviors
or interests [1]. However, ASD is highly heterogeneous in
terms of clinical symptoms and etiology. Although ASDs
are highly heritable, and recent advances in next gener-
ation sequencing have revealed more than 1000 mutations
associated with ASD, most of those identified alleles are
rare variants that represent only a small fraction of ASD
[2]. Moreover, it is becoming clear that ASD involves mul-
tigenic interactions, as well as interactions between risk
genes and various environmental factors, which further
highlight its complexity [2, 3].
Mutations in SHANK genes are associated with ASD
and other psychiatric conditions such as intellectual dis-
abilities, schizophrenia, and Phelan-Mcdermid Syndrome
[4, 5]. SHANK genes (SHANK1, 2, 3) encode the SH3 and
multiple ankyrin repeat domain proteins, which are post-
synaptic scaffold proteins of excitatory synapses [6, 7].
Among SHANK genes, over 80 and 30 ASD-associated
mutations have been identified in SHANK3 and SHANK2,
respectively (https://gene.sfari.org/database/human-gene/)
[8, 9]. While Shank3 mutant mice have been most exten-
sively characterized, previous studies demonstrated that
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Shank2 null mutant mice also exhibit ASD-like behavioral
deficits and synaptic dysfunctions [7, 10–12]. Interestingly,
Shank2 KO mice lacking exons 6 and 7 (Shank2 e6–7
KO) showed hypo-function of N-methyl-D-aspartate re-
ceptor (NMDAR) and impaired long-term potentiation
(LTP), whereas the other Shank2 mutant lacking exon 7
of the Shank2 gene (e7 KO) showed hyper-function of
NMDAR and enhanced LTP in the adult hippocampus
[10, 11]. Recent studies showed that differences in gene
expressions, experimental conditions, genetic background,
and the developmental stages of the mice may, at least
partially, explain the opposite cellular phenotypes in the
two Shank2 mutant mouse models [13–15]. We have pre-
viously compared the gene expression profiles of Shank2
e6–7 and e7 KO mice by performing RNA-seq analyses,
and found that the two KO mouse lines share only a few
differentially expressed genes [14]. In this study, we ana-
lyzed RNA-seq data from the hippocampi of two Shank2
mutant mouse models (e7 and e6–7 KO), and found a
novel transcript that encodes a new exon in e6–7 and e7
KO mice. We confirmed the expression of this novel tran-
script at both mRNA and protein levels, which suggested
that this novel variant may act as a modifier gene that




The RNA-Seq raw reads [GSE79824 (GSM2104342 -
GSM2104353) and GSE47966] were processed and mapped
against the mouse genome, as previously described [14]. The
uniquely mapped reads were used to reconstruct Shank2
gene transcripts (guided transcriptome reconstruction), as
previously described [16]. The transcribed regions based on
the mapped RNA-Seq reads were analyzed to detect possible
novel exons in the known gene. The spliced junction reads
between a known exon and a novel exon were used to con-
firm the expression of the novel exon and to reconstruct the
transcript isoforms. Conserved regions on the novel exon
were evaluated using the comparative genomics tracks in the
UCSC genome browser. Multiple sequence alignments
among eight different species (human, rhesus, mouse, rat,
dog, cow, chicken and frog) was performed using the
MUSCLE algorithm implemented in EMBL-EBI bioinfor-
matics tools [17]. Based on the multiple sequence alignment
result, a phylogenetic tree was constructed using the
neighbor-joining method implemented in MEGA [18].
Methylation information in the mouse genome was obtained
from the “DNA Methylation” track hub in the UCSC gen-
ome browser provided by MethBase [19].
Quantitative real time polymerase chain reaction (PCR)
Total RNA samples were extracted from the prefrontal
cortex, hippocampus, and cerebellar hemisphere region
of 4-week and 8-week old male C57BL/6 N mice (Orient
Bio). cDNA was extracted from total RNA by reverse-
transcription using SuperScript III (Invitrogen) for RNA-
seq. Primer sequences used were as follows: forward 5′-
CGGTCTGAGTGAGATGGTCA-3′ (exon 4′) and re-
verse 5′-TAGGAGCCCACCGTGTAATG-3′ (exon 5).
Quantitative RT-PCR was performed with SYBR Premix
Ex Taq II (Tli RNase H Plus) (Takara) on the ABI7300
instrument. Initial activation was conducted at 95 °C for
30 s. This was followed by 40 cycles of 95 °C for 5 s and
60 °C for 30 s. Single peaks from dissociation cycles were
confirmed, which were indicative of a single PCR prod-
uct. The 2-ΔΔCt method was used for quantitative com-
parison, using GAPDH as the control. RT-PCR was
performed using Kapa HiFi Hotstart Readymix (Kapa
Biosystems). Initial activation at 94 °C was carried out
for 30 s, and was followed by 34 cycles of 94 °C for 30 s
and 58 °C for 30 s (Actb and ex4’f-ex5r), or 60 °C for 30 s
(ex2f-ex4r and ex4f-ex6r) and 72 °C for 60 s. The RT-
PCR products were visualized in agarose gels.
Western blot
Western blot analyses were performed as previously de-
scribed [14, 20]. Membranes were incubated with a rabbit
anti-SHANK2 (ab171189, Abcam) or anti-tubulin (T4026,
Sigma) antibodies overnight at 4 °C, followed by incubation
with an appropriate HRP-conjugated secondary antibody for
2 h at room temperature. Chemiluminescence signals were
acquired and analyzed using ChemiDoc (Bio-Rad).
Results
Identification and validation of a novel transcript
We extended our comparative transcriptome analysis by
measuring expression densities through the transcripts,
including intronic regions. Previous studies have identi-
fied multiple splicing variants of Shank2, including short
Shank2a and long Shank2b [21, 22]. In this study, we
also identified a previously unknown intronic region via
RNA sequencing mapping, which suggests that there
may be an additional Shank2 splicing variant in the
mouse hippocampus (Fig. 1a). To characterize the region
in more detail and determine whether the identified ex-
pression region was a true transcribed region, we recon-
structed KO and wild type (WT) Shank2 transcripts
based on the RNA raw sequencing reads (Fig. 1a). The
reads from the spliced junction between the known
exons and newly identified transcribed regions were
used to confirm the expression of the novel exon. We
were able to reconstruct Shank2 transcripts in each sam-
ple (e6–7 KO, e6–7 WT littermate, e7 KO, and e7 WT
littermate), and confirmed the previously known tran-
scripts (Fig. 1a). We identified the transcribed regions,
chr7:144238708–144,239,093 (e6–7 KO) and chr7:
144238699–144,239,093 (e7 KO) (red box in Fig. 1a),
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Fig. 1 Identification of the novel exon 4′ in Shank2 KO mice and validation of mRNA and protein expression of this transcript. a Read distribution plots
and transcript structures in e6–7 and e7 knockout (KO) and their own wild type (WT) littermate samples. RNA-Seq data (NCBI GEO GSE79824;
GSM2104342 - GSM2104353) were processed as described in the method section. Blue color represents WT samples and red color represents KO
samples. Red box shows the identified novel exon 4′ in KO samples. b Real time quantitative PCR using primers that span exon 4′ and 5. Five
hippocampi per group were used for the analysis; experiments were carried out in triplicates. c A schematic exonic diagram of translated proteins
from the different Shank2 transcripts. d Western blot analysis of the Shank2 proteins. The long (Shank2b) and short (Shank2a) Shank2 isoforms were
detected in WT, which were completely missing in e6–7 KO. In e6–7 KO, a clear band for the novel isoform (red arrow) was detected slightly below
the band for Shank2a. The difference between the two bands are emphasized in a different electrophoresis condition (Fig. S1)
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which were located in exons 4 and 5 of the Shank2 tran-
script in the reconstructed e6–7 and e7 KO transcripts.
This novel transcribed region has not been previously
annotated in any gene annotation database, and we an-
notated the novel transcribed region as exon 4′. We
found that the novel exon 4′ is connected with exon 5,
but not with the upstream exons; therefore, exon 4′ is
the first exon of this novel transcript. More interestingly,
although expression of the novel transcript containing
exon 4′ was detected in both e6–7 and e7 KO, but very
weakly in e7 KO (Fig. 1a).
To verify the expression of the novel Shank2 transcript
containing the newly discovered exon 4′, we designed
PCR primers with the forward primer in exon 4′ (ex4’f)
and the reverse primer in exon 5 (ex5r) (Table 1). Quan-
titative RT-PCR detected a single PCR product, confirm-
ing the existence of the exon 4′-5 containing transcript.
Expression of the novel transcript was markedly in-
creased by approximately 8 folds in the e6–7 KO com-
pared with that of e6–7 WT littermate (Fig. 1b).
However, consistent with the RNA-Seq results, expres-
sion of the novel transcript was considerably less in-
creased in e7 KO (~ 1.71 fold compared with that of ex7
WT littermate, Fig. 1b). To further confirm that the
novel transcript is translated into a protein of the ex-
pected size in the brains of e6–7 KO mice (Fig. 1c), we
performed western blot analyses. A clear protein band
was detected slightly below the band for Shank2a only
from the cortex and hippocampus of e6–7 KO mice
(Fig. 1d and Fig. S1). Both long (Shank2b) and short
(Shank2a) Shank2 isoforms were not detected in e6–7
KO mice, which confirmed the specificity of the anti-
body (Fig. 1d and Fig. S1). Although expression of the
novel transcript was also increased in e7 KO, it would be
difficult to be detected in western blot due to its relatively
lower expression level compared with that in e6–7 KO.
Characterization of the novel transcript
Unexpectedly, when we analyzed phylogenetic conserva-
tion of exon 4′ in the UCSC genome browser using
comparative genomics tracks (conservation, Placentral
Chain/Net, and Vertebrate Chain/Net), we found that it
is well-conserved across vertebrate animals, except for
fish species. As shown in Fig. 2a, there are two highly con-
served regions. One of the conserved regions is located
upstream of exon 4′ (left dotted black box in Fig. 2a),
which could serve as the promoter for its expression. The
other highly conserved region is located at the end of exon
4′ (right dotted black box in Fig. 2a), which could be the
protein coding region in the novel transcript. We ex-
tracted DNA sequence that spans across the novel exon
4′ sequence, as well as 200 bp upstream of the exon 4′ se-
quence from eight different representative vertebrate spe-
cies (except birds). Multiple sequence alignment and
phylogenetic analyses were conducted. Expectedly, the
overall sequence was well-aligned among the species, and
the phylogenetic tree among the eight different species re-
vealed that no evidence showing rapid evolutionary rate
change was observed (Fig. S2).
We assessed the methylation profiles of regions near
exon 4′ in several tissues using the DNA methylation
hub track in the UCSC genome browser. Interestingly,
there are overlaps between the exon 4′ region and hypo-
methylated regions in several tissues (Fig. 2b). Especially,
the hypomethylated regions in brain tissues are associ-
ated with the tissue-specific epigenetic reconfigurations
during mammalian brain development [23]. Therefore,
the novel exon 4′ is not only evolutionary conserved,
but may also play functional roles in the brain.
Expression of novel transcripts in wild type mouse brain
To determine whether the novel transcript is constitu-
tively expressed in wild type mouse brains, we investi-
gated the public brain transcriptome data from the study
by Lister et al. [23]. They determined the temporal gene
expression profiles of the mouse frontal cortex from fetal
to 22-month-old mice using RNA sequencing. We col-
lected and analyzed the RNA-Seq data for the following
three data time points: fetal, 4-week-old, and 22-month-
old. After constructing the Shank2 gene isoforms, as
previously described, we confirmed that the novel tran-
scripts were expressed in all time points (Fig. 3a). Fur-
thermore, we performed RT-PCR using extracted RNAs
from 4-week-old and 8-week-old wild type C57Bl/6 N
mouse brain regions (prefrontal cortex, PFC; hippocam-
pus, HPC; and cerebellum, CBL). Three different primer
pairs were used to detect the known and novel tran-
scripts (ex2f-ex4r, ex4f-ex6r: known transcript; ex4’f-
ex5r: novel transcript) (Fig. 3a black arrows). As shown
in Fig. 3b, we confirmed that both known and novel
transcripts were expressed in each brain region.
Discussion
We occasionally observe conflicting, heterogeneous phe-
notypes in the same genetic mutant lines associated with
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ASD. In addition to the two Shank2 KO lines studied
here, mutant mouse lines of another Shank isoform, in
which either exons 4–9 or exons 4–7 of Shank3 have been
deleted, showing different synaptic and behavioral pheno-
types when compared to each other [24–26]. Epac2 KO
mice, another ASD mouse model that lacks either exon 1
or 3 also shows distinct behavioral and electrophysio-
logical phenotypes [27–29]. However, the molecular
mechanism underlying the different phenotypes in same
gene mutant lines still remains unclear. In the previous
study [14], we profiled whole transcriptome expressions
for Shank2 e6–7 KO and e7 KO mouse models and found
that expression of the Gabra2 gene was reduced in e6–7
KO mice, but not in e7 KO mice when compared to their
own WT littermates; this may partially contribute to dif-
ferences between Shank2 e6–7 KO and e7 KO mice.
Fig. 2 Genomic landscape of the novel exon 4′ in Shank2. a UCSC genome browser conservation track (Placental Cons) for regions around exon
4′. Dotted black boxes indicate highly conserved regions. b UCSC DNA methylation tracks. DNA methylation changes are shown as blue or red
(near exon 4′) boxes. Red boxes represent the regions near the identified novel exon. Black arrows indicate known exons in the Shank2 transcript.
Red arrow indicates exon 4′
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In this study, we identified a novel Shank2 transcript,
which has not been previously reported. It is rather sur-
prising that the novel exon 4′ has not been annotated
yet considering that we found that it is well-conserved
across vertebrates. Relatively lower expression level of
the transcript harboring the exon 4′ compared to the
previously identified isoforms may have hindered the
identification of this novel transcript. To validate this
novel transcribed region, we computationally recon-
structed transcript isoforms and experimentally con-
firmed the expression of the identified region using
quantitative RT-PCR. In the reconstructed e6–7 KO and
e7 KO transcripts, the novel transcribed region (novel
exon 4′) was connected to the downstream exon 5.
However, we were unable to detect the reconstructed
transcripts containing the novel exon 4′ in WT samples
because the RNA sequencing (RNA-Seq) depth was not
enough. Furthermore, as shown in the RNA-Seq expres-
sion profile of the transcripts, expression level of the
novel exon 4′ in e6–7 KO mice was greater than e7 KO
mice, as determined by quantitative RT-PCR (Fig. 1b).
This aberrant increase in exon 4′ expression in e6–7 KO
mice may also contribute to the observed differences in
the two Shank2 KO mutants, which remains to be exam-
ined. It would be interesting to examine whether ectopic
expression of the cloned novel isoform in either WT or
e7 KO mice can recapitulate, at least, some phenotypes
in e6–7 KO.
Gene regulation is a complicated process and is finely
tuned in different settings. Many studies have shown that
epigenetic profiles such as methylation can affect differen-
tial isoform expressions [30]. For example, intragenic
DNA methylome map of the brain has shown that tissue-
specific DNA methylation in the Shank3 gene regulates
promoter activity, and that differential DNA methylation
patterns are associated with alternative transcript expres-
sions in tissue- and cell type-specific manners in the brain
regions [31]. Our study showed that regions near the
novel exon 4′ were phylogenetically well-conserved across
vertebrate species and were hypomethylated in several
mouse tissues, including the brain tissues. We speculate
that the deletion of exon 6 and 7 may have affected the
methylation status of the region near the novel exon 4′,
which subsequently increases the expression of the novel
Shank2 transcript. Alternatively, other epigenetic modifi-
cations or chromatin reorganization, such as changes in
nucleosome and positioning may have occurred in e6–7
KO. Further analyses would be required to test the sug-
gested hypothesis.
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